Under the terms of the Warrant Agreement, the Company has the right to redeem all of the outstanding Warrants if the reported ...

GT Biopharma, Inc. announced that it has entered into agreements to exercise existing warrants for a total of 302,069 shares of its common stock at an exercise price of $4.35, which were issued in May ...

Wearable Devices (WLDS) stock rose nearly 5% in pre-market trading on Friday after the company announced that it entered into ...

The stock jumped as much as 2,000% from its bottom in late June to its peak in September, as the rally culminated with ...

BOSTON--(BUSINESS WIRE)--Netcapital Inc. (the “Company”) (NASDAQ: NCPL, NCPLW), a digital private capital markets ecosystem, today announced the entry into definitive agreements for the immediate ...

HCW Biologics Inc. ('HCWB” or the 'Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on ...

MIAMI, June 24, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie ...

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced an offer to exercise its outstanding publicly traded warrants (the “Warrants”) at a temporarily reduced price (the ...

MARLBOROUGH, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make ...

Palisade Bio, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases, announced the agreement with accredited investors to exercise ...

Cipher Mining (CIFR) delivered a notice of redemption to redeem all of its outstanding warrants to purchase shares of the Company’s common stock, ...